Neurodegenerative phenotypes in an A53T -synuclein transgenic mouse model are independent of LRRK2
Year: 2012
Type: article
Abstract: Mutations in the genes encoding LRRK2 and α-synuclein cause autosomal dominant forms of familial Parkinson's disease (PD). Fibrillar forms of α-synuclein are a major component of Lewy bodies, the intracytoplasmic proteinaceous inclusions that are a pathological hallmark of idiopathic and certain familial forms of PD. LRRK2 mutations cause late-onset familial PD with a clinical, neurochemical and, for the most part, neuropathological phenotype that is indistinguishable from idiopathic PD. Importantly, α-synuclein-positive Lewy bodies are the most common pathology identified in the brains of PD subjects harboring LRRK2 mutations. These observations may suggest that LRRK2 functions in a common pathway with α-synuclein to regulate its aggregation. To explore the potential pathophysiological interaction between LRRK2 and α-synuclein in vivo, we modulated LRRK2 expression in a well-established human A53T α-synuclein transgenic mouse model with transgene expression driven by the hindbrain-selective prion protein promoter. Deletion of LRRK2 or overexpression of human G2019S-LRRK2 has minimal impact on the lethal neurodegenerative phenotype that develops in A53T α-synuclein transgenic mice, including premature lethality, pre-symptomatic behavioral deficits and human α-synuclein or glial neuropathology. We also find that endogenous or human LRRK2 and A53T α-synuclein do not interact together to influence the number of nigrostriatal dopaminergic neurons. Taken together, our data suggest that α-synuclein-related pathology, which occurs predominantly in the hindbrain of this A53T α-synuclein mouse model, occurs largely independently from LRRK2 expression. These observations fail to provide support for a pathophysiological interaction of LRRK2 and α-synuclein in vivo, at least within neurons of the mouse hindbrain.
Source: Human Molecular Genetics
DOI: 10.1093/hmg/dds057
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: National Science Foundation, Alzheimer's Association, National Parkinson Foundation, Adrienne Helis Malvin Medical Research Foundation, École Polytechnique Fédérale de Lausanne, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Vetenskapsrådet, Swedish Brain Power, National Institutes of Health, Parkinsonfonden, National Institute on Aging, National Institute of Neurological Disorders and Stroke
Awards: G1378659243, Molecular Mechanisms Underlying Neuronal Hypertrophy in Asymptomatic Alzheimer's Disease, SYNUCLEINS--CELL BIOLOGY AND TRANSGENIC MICE, LRRK2 Cell Biology and Parkinson's Disease, Neurodegenerative interactions in conditional LRRK2 Tg models, Synucleins: Cell biology and transgenic mice, Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50), Johns Hopkins Alzheimer's Disease Research Center, Synucleins: Cell biology and transgenic mice, G8690818240
OpenAlex ID: W2116510706
